Skip to main content
    A

    Azenta Inc (AZTA)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $36.52
    -0.66 (-1.78%)

    Market Cap: $1.66B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    87%(34/39)
    Avg Surprise
    +55.41%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.02
    Range$-0.11 - $0.05
    4 analysts
    Revenue Consensus
    $170M
    Range$168M - $171M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.13
    Range$0.09 - $0.16
    2 analysts
    EPS RevisionsNo revisions (7d)
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.14-10.7%
    60d ago$0.14-10.7%
    30d ago$0.12+7.1%
    7d ago$0.130.0%
    Current$0.13
    Revenue Consensus
    $157M
    Range$157M - $157M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.13---
    Sep 26EST
    		-$-0.02---
    Jun 26
    Reported Aug 4
    		$0.16$0.10+60.00%Beat-15.8%
    Mar 26
    Reported May 6
    		$-0.04N/A-128.57%Miss-180.0%
    Dec 25
    Reported Feb 4
    		$0.09$0.13-30.77%Miss+12.5%
    Sep 25
    Reported Nov 21
    		$0.21$0.20+5.00%Beat+16.7%
    Jun 25
    Reported Aug 5
    		$0.19$0.14+35.71%Beat+18.8%
    Mar 25
    Reported May 7
    		$0.05$0.07-28.57%Miss+0.0%
    Dec 24
    Reported Feb 5
    		$0.08$0.06+33.33%Beat+300.0%
    Sep 24
    Reported Nov 12
    		$0.18$0.11+63.64%Beat+38.5%
    Jun 24
    Reported Aug 6
    		$0.16$0.07+128.57%Beat+23.1%
    Mar 24
    Reported May 8
    		$0.05$0.02+150.00%Beat+183.3%
    Dec 23
    Reported Feb 7
    		$0.02$-0.03+166.67%Beat-83.3%
    Sep 23
    Reported Nov 13
    		$0.13$0.02+550.00%Beat-18.8%
    Jun 23
    Reported Aug 8
    		$0.13$-0.02+750.00%Beat+8.3%
    Mar 23
    Reported May 9
    		$-0.06$-0.02-200.00%Miss-150.0%
    Dec 22
    Reported Feb 8
    		$0.12$0.10+20.00%Beat+0.0%
    Sep 22
    Reported Nov 14
    		$0.16$0.07+128.57%Beat-79.5%
    Jun 22
    Reported Aug 9
    		$0.12$0.09+33.33%Beat-83.3%
    Mar 22
    Reported May 9
    		$0.12$0.11+9.09%Beat-80.3%
    Dec 21
    Reported Feb 8
    		$0.12$0.08+50.00%Beat-74.5%
    Sep 21
    Reported Nov 10
    		$0.78$0.77+1.30%Beat+66.0%
    Jun 21
    Reported Aug 5
    		$0.72$0.69+4.35%Beat+125.0%
    Mar 21
    Reported May 10
    		$0.61$0.51+19.61%Beat+144.0%
    Dec 20
    Reported Feb 2
    		$0.47$0.42+11.90%Beat+104.3%
    Sep 20
    Reported Nov 10
    		$0.47$0.36+30.56%Beat+95.8%
    Jun 20
    Reported Jul 30
    		$0.32$0.20+60.00%Beat+60.0%
    Mar 20
    Reported Apr 30
    		$0.25$0.25+0.00%Beat+47.1%
    Dec 19
    Reported Feb 6
    		$0.23$0.24-4.17%Miss+35.3%
    Sep 19
    Reported Nov 6
    		$0.24$0.23+4.35%Beat-40.0%
    Jun 19
    Reported Aug 1
    		$0.20$0.16+25.00%Beat-56.5%
    Mar 19
    Reported Apr 29
    		$0.17$0.10+70.00%Beat-57.5%
    Dec 18
    Reported Feb 5
    		$0.17$0.13+30.77%Beat-46.9%
    Sep 18
    Reported Nov 19
    		$0.40$0.38+5.26%Beat+14.3%
    Jun 18
    Reported Aug 6
    		$0.46$0.43+6.98%Beat+27.8%
    Mar 18
    Reported May 1
    		$0.40$0.36+11.11%Beat+42.9%
    Dec 17
    Reported Feb 1
    		$0.32$0.29+10.34%Beat+28.0%
    Sep 17
    Reported Nov 9
    		$0.35$0.29+20.69%Beat-
    Jun 17
    Reported Aug 2
    		$0.36$0.30+20.00%Beat-
    Mar 17
    Reported Apr 27
    		$0.28$0.25+12.00%Beat-
    Dec 16
    Reported Feb 1
    		$0.25$0.20+25.00%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    FrequencyQuarterly

    Key Metrics

    Valuation
    P/E Ratio86.95EV/EBITDAN/A
    Price/FCF167.38xFCF Yield0.60%
    Profitability
    Profit Margin-20.00%Operating Margin-2.27%
    ROE-7.04%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.50xQuick Ratio2.21x
    Trading Statistics
    Beta1.52Avg Volume1.22M
    52-Week High$46.4152-Week Low$15.93

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$37.98
    SMA 20$36.06
    SMA 50$34.13
    SMA 200$28.32
    EMA 10$37.02
    EMA 20$36.15
    EMA 50$33.79
    EMA 200$29.67

    MACD

    Line: 1.23Signal: 1.33Hist: -0.10

    ADX

    ADX: 33.2+DI: 35.4-DI: 20.1

    Aroon & PSAR

    Aroon Up72.0
    Aroon DownN/A
    PSAR$44.11

    Bollinger Bands

    Upper Band$40.90
    Lower Band$31.22
    %B Position2684%(Upper)
    Band Width0.55

    RSI (14-Day)

    Neutral
    53.6

    Momentum Oscillators

    Stoch %K29.8
    Stoch %D32.3
    Williams %R-75.3
    ROC (10d)5.9%
    Momentum2.04
    CCI (20d)5.5
    MFI (14d)70.6

    Volatility Measures

    ATR (14d)$2.10(5.7%)
    StdDev (20d)2.42
    Hist Vol75.9%(High)

    Volume Flow

    VWAP$36.27
    OBV13.0M
    AD Line8.9M
    CMF (20d)0.002

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio0.9x
    VWMA (20d)$36.91

    Pivot Points

    R3$40.25
    R2$39.58
    R1$38.38
    Pivot Point$37.72
    S1$36.52
    S2$35.85
    S3$34.65

    Advanced Oscillators

    TSI17.32
    Ultimate Osc47.2
    KST137.84

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$161.18M$144.79M$148.64M$158.95M$143.85M$143.34M$147.44M$151.08M$144.29M$136.35M$141.72M$58.77M
    Cost of Revenue$88.82M$82.76M$84.94M$90.99M$77.45M$80.56M$78.62M$84.34M$78.81M$75.69M$79.98M$14.67M
    Gross Profit$72.36M$62.03M$63.71M$67.96M$66.40M$62.78M$68.82M$66.74M$65.48M$60.66M$61.74M$44.10M
    Operating Expenses$76.53M$227.82M$70.94M$66.59M$68.25M$80.98M$77.52M$70.46M$72.58M$84.88M$77.99M$48.85M
    R&D$8.85M$9.43M$9.19M$10.46M$7.42M$7.60M$7.11M$9.57M$6.91M$7.73M$7.31M$7.12M
    SG&A$67.17M$67.89M$60.61M$55.73M$60.08M$69.80M$69.98M$60.04M$63.97M$69.06M$69.89M$22.38M
    Operating Income$-4,178,000$-165,790,000$-7,237,000$1.37M$-1,850,000$-18,194,000$-8,701,000$-3,720,000$-7,106,000$-24,213,000$-16,245,000$-4,748,000
    Interest Income$3.83M$4.39M$5.10M$5.02M$4.97M$4.49M$4.30M$5.53M$7.92M$9.48M$9.96M$11.13M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$846,000$-157,344,000$-2,060,000$5.78M$2.30M$-12,547,000$-3,199,000$1.21M$442,000$-15,002,000$-5,772,000$4.79M
    Income Tax Expense$2.38M$-323,000$3.13M$-45,608,000$2.63M$7.24M$3.87M$2.02M$600,000$1.20M$1.42M$-2,858,000
    Net Income$2.46M$-160,798,000$-15,432,000$50.84M$-47,987,000$-47,661,000$-10,992,000$-5,711,000$-6,582,000$-136,880,000$-15,724,000$3.00M
    EBITDA$10.20M$-148,037,000$6.12M$14.93M$11.72M$-3,525,000$10.06M$18.19M$12.58M$-3,513,000$5.43M$14.87M
    EBIT$-2,979,000$-161,731,000$-7,158,000$757,000$-2,670,000$-17,036,000$-7,497,000$-4,325,000$-7,483,000$-24,481,000$-15,727,000$-6,344,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about AZTA

    Government Contracts

    Gov Obligations (TTM)
    $12.86M
    Gov Obligations / Revenue
    2.2%
    Obligations YoY
    N/A
    Active Awards
    14
    New Awards (TTM)
    5
    Avg Remaining Term
    11.9 mo

    Top agency: Department of Health and Human Services at 96.9% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N98026P01109Department of Health and Human ServicesNational Institutes of Health$5.54MJul 31, 2026
    140D0425P0165Department of the InteriorDepartmental Offices$695604Sep 25, 2025
    36C26026P0555Department of Veterans AffairsDepartment of Veterans Affairs$50000Jul 1, 2026
    36C26126P0469Department of Veterans AffairsDepartment of Veterans Affairs$20000Mar 30, 2026
    75N98026P00576Department of Health and Human ServicesNational Institutes of Health$18880May 20, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Azenta, Inc. Investor News: If You Have Suffered Losses in

    The Rosen Law Firm is investigating potential securities claims on behalf of Azenta, Inc. (NASDAQ: AZTA) shareholders who may have suffered losses due to allegedly misleading business information. The investigation...

    GlobeNewswire•10/13/26•Bearish

    Azenta, Inc. Investor News: If You Have Suffered Losses in

    The Rosen Law Firm is investigating potential securities claims against Azenta, Inc. (NASDAQ: AZTA) following allegations of misleading business information. This investigation comes after Azenta's stock fell 12%...

    GlobeNewswire•10/13/26•Bearish

    Azenta, Inc. (AZTA) Stock Forecasts

    Argus has raised its target price for Azenta Inc. (AZTA) to $41.00. Azenta Inc. is described as a provider of life sciences solutions that facilitates faster breakthroughs and therapies. The report also mentions...

    Yahoo! Finance Canada•10/11/26•Bullish

    Azenta, Inc. Investor News: If You Have Suffered Losses in

    The Rosen Law Firm is investigating potential securities claims on behalf of Azenta, Inc. (NASDAQ: AZTA) shareholders who suffered losses. This investigation follows the resignation of Azenta's President and CEO...

    GlobeNewswire•10/10/26•Bearish

    Azenta Inc (BA3.MU) Analyst insights, Price targets and Recommendations

    This article provides analyst insights, price targets, and recommendations for Azenta Inc (BA3.MU). It lists several reiterations of "Buy" and "Outperform" ratings from Needham and Evercore ISI Group between September...

    Yahoo Finance UK•10/7/26•Neutral

    AZTA Valuation and Fair Value

    P/E
    87.0x
    Forward P/E
    29.1x
    P/FCF
    167.4x
    PEG
    0.5x
    P/B
    1.1x
    See GNG's fair value

    AZTA Profitability: Margins, ROIC and FCF

    Gross margin
    43.4%
    Operating margin
    -2.3%
    Net margin
    -20.0%
    ROE
    -7.0%
    FCF margin
    1.6%
    FCF yield
    0.6%

    AZTA Competitors

    CompanyTicker
    Novocure LtdNVCR
    Biohaven Ltd.BHVN
    Intellia Therapeutics IncNTLA
    Nuvation Bio IncNUVB
    Dentsply Sirona IncXRAY
    Omnicell IncOMCL
    Septerna, Inc. Common StockSEPN
    Forte Biosciences IncFBRX

    Sector: Healthcare

    AZTA Analyst Ratings

    Consensus
    Buy
    Analysts
    6
    Strong Buy
    1
    Buy
    2
    Hold
    3
    Sell
    0
    Strong Sell
    0

    AZTA Bull Case vs Bear Case

    Bull case

    • AZTA grew quarterly revenue 12.0% year over year.

    Bear case

    • AZTA trades at 87.0x trailing earnings.
    • AZTA has a -20.0% net profit margin.

    AZTA Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    1.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.02

    AZTA Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About AZTA

    Does AZTA pay dividends?

    Azenta Inc (AZTA) has a dividend payment track record. See the AZTA dividend history page for its current payment status, TTM yield, and recorded payments.

    What is AZTA's P/E ratio?

    Azenta Inc has a price-to-earnings (P/E) ratio of 86.95.

    What is AZTA's market cap?

    Azenta Inc (AZTA) has a market capitalization of $1.66B with a current stock price of $36.52.

    Related stocks

    Sector: Healthcare

    All stocks starting with A

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In